Director at First Tracks Biotherapeutics (TRAX) granted options and RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
First Tracks Biotherapeutics director Rita Jain received new equity awards in the form of options and restricted stock units. She was granted options to buy 42,000 shares of common stock at an exercise price of $17.81 per share, expiring on May 11, 2036.
She also received 15,000 restricted stock units, each representing one share of common stock upon settlement for no cash consideration. The RSUs vest 100% on the date of the company’s 2027 annual shareholder meeting, while the options vest in 12 equal monthly installments starting June 12, 2026 as long as she continues serving the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Jain Rita
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 15,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 42,000 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 15,000 shares (Direct, null);
Stock Option (right to buy) — 42,000 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. In addition to the options to purchase a total of 42,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 57,135 shares of common stock, which options vest according to their terms.
Key Figures
Option grant size: 42,000 shares
Option exercise price: $17.81 per share
Option expiration: May 11, 2036
+3 more
6 metrics
Option grant size
42,000 shares
Stock options granted on May 12, 2026
Option exercise price
$17.81 per share
Exercise price for 42,000 options
Option expiration
May 11, 2036
Final expiry of granted options
RSU grant size
15,000 units
Restricted stock units granted May 12, 2026
Additional existing options
57,135 shares
Other options already held by reporting person
RSU vesting date
2027 annual meeting
RSUs vest 100% at 2027 shareholder meeting
Key Terms
Restricted Stock Unit, stock option, exercise price, annual meeting of shareholders, +1 more
5 terms
Restricted Stock Unit financial
"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "17.8100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests financial
"The stock option vests as to 1/12 of the total shares monthly"
FAQ
What equity awards did TRAX director Rita Jain receive in this Form 4?
Rita Jain received a grant of options to buy 42,000 shares of First Tracks Biotherapeutics common stock and 15,000 restricted stock units. These awards are compensation-related and increase her potential future equity ownership, subject to vesting and continued service with the company.
What is the exercise price and term of Rita Jain’s TRAX stock options?
The options allow purchase of 42,000 First Tracks Biotherapeutics shares at an exercise price of $17.81 per share. They expire on May 11, 2036, giving a long-dated window to exercise if vesting and other conditions are satisfied over time.
How and when do Rita Jain’s TRAX restricted stock units vest?
The 15,000 restricted stock units vest as to 100% of the total on the date of First Tracks Biotherapeutics’ 2027 annual meeting of shareholders. Vesting requires Rita Jain to continue providing service to the company through that meeting date.
What is the vesting schedule for Rita Jain’s TRAX stock options?
The 42,000 stock options vest in 12 equal monthly installments starting June 12, 2026, continuing until fully vested. Each monthly tranche requires Rita Jain to remain in service with First Tracks Biotherapeutics on the applicable vesting date.
Does Rita Jain hold other TRAX options besides this new grant?
Yes. In addition to the newly granted options for 42,000 shares, she holds existing options to purchase up to an aggregate of 57,135 First Tracks Biotherapeutics common shares. Those earlier awards continue to vest according to their original terms.